A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma
Figure 1
Scatter plot for Days to Tumor Recurrence vs. expression of the mesenchymal transition metagene.
Each dot in the scatter plot represents one of the 99 patients for which the “Days to Tumor Recurrence” phenotype has a non-null entry. The horizontal axis measures the average of the RMA-normalized expression levels of the 64 genes shown in Table 1. The vertical axis measures the days to tumor recurrence and the horizontal dotted line is drawn at the 3 year cutoff point.
